![]() Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSD17B2 mRNA] | CTD | PMID:31150632 | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of HSD17B2 mRNA | CTD | PMID:25380136, PMID:30723492 | 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:1353008 | 6480464 | [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of HSD17B2 mRNA | CTD | PMID:27344345 | 17beta-estradiol | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Estradiol | CTD | PMID:16054388 | 17beta-estradiol | increases expression | ISO | RGD:733207 | 6480464 | Estradiol results in increased expression of HSD17B2 mRNA | CTD | PMID:30077407 | 17beta-estradiol | multiple interactions | ISO | RGD:733207 | 6480464 | [Polyphenols co-treated with Estradiol] results in increased expression of HSD17B2 mRNA | CTD | PMID:30077407 | 17beta-estradiol | affects binding | ISO | RGD:1353008 | 6480464 | Estradiol binds to HSD17B2 protein | CTD | PMID:21972996 | 17beta-estradiol | decreases expression | ISO | RGD:1353008 | 6480464 | Estradiol results in decreased expression of HSD17B2 mRNA | CTD | PMID:20106945, PMID:21632981 | 17beta-estradiol | multiple interactions | ISO | RGD:1353008 | 6480464 | 6-(4-hydroxy-3-(trifluoromethyl)phenyl)-1-naphthol inhibits the reaction [Estradiol binds to HSD17B2 protein] more ... | CTD | PMID:17404688 more ... | 17beta-estradiol | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Estradiol | CTD | PMID:16054388 | 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | ISO | RGD:733207 | 6480464 | 2 more ... | CTD | PMID:20005886 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:733207 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of HSD17B2 mRNA more ... | CTD | PMID:16214954 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:733207 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B2 mRNA | CTD | PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733207 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B2 mRNA | CTD | PMID:20702594, PMID:26377647 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733207 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:17949056 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1353008 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:20106945 more ... | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of HSD17B2 mRNA | CTD | PMID:16054898 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of HSD17B2 mRNA | CTD | PMID:20959002, PMID:21215274 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B2 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1353008 | 6480464 | Tetrachlorodibenzodioxin affects the expression of HSD17B2 mRNA | CTD | PMID:22298810 | 2,3,7,8-Tetrachlorodibenzofuran | affects expression | ISO | RGD:733207 | 6480464 | 2 more ... | CTD | PMID:20702594 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of HSD17B2 mRNA | CTD | PMID:21346803 | 2-amino-4,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2-amino-4, 6-dinitrotoluene affects the expression of HSD17B2 mRNA | CTD | PMID:21346803 | 2-hydroxypropanoic acid | decreases expression | ISO | RGD:1353008 | 6480464 | Lactic Acid results in decreased expression of HSD17B2 mRNA | CTD | PMID:30851411 | 2-methoxy-17beta-estradiol | multiple interactions | ISO | RGD:1353008 | 6480464 | [HSD17B2 protein results in increased metabolism of and results in decreased activity of 2-Methoxyestradiol] which results in increased chemical synthesis of 2-methoxyestrone | CTD | PMID:16397246 | 2-methoxy-17beta-estradiol | decreases response to substance | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in decreased susceptibility to 2-Methoxyestradiol | CTD | PMID:16397246 | 2-methoxyestrone | multiple interactions | ISO | RGD:1353008 | 6480464 | [HSD17B2 protein results in increased metabolism of and results in decreased activity of 2-methoxyestradiol] which results in increased chemical synthesis of 2-methoxyestrone | CTD | PMID:16397246 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | EXP | | 6480464 | 3 more ... | CTD | PMID:19692669 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of HSD17B2 mRNA | CTD | PMID:26988606 | 3,4-dichloroaniline | increases expression | ISO | RGD:1353008 | 6480464 | 3, 4-dichloroaniline results in increased expression of HSD17B2 mRNA | CTD | PMID:24172598 | 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4, 4'-diaminodiphenylmethane results in decreased expression of HSD17B2 mRNA | CTD | PMID:25380136 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:733207 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of HSD17B2 mRNA | CTD | PMID:30951980 | 5-fluorouracil | affects expression | ISO | RGD:1353008 | 6480464 | Fluorouracil affects the expression of HSD17B2 mRNA | CTD | PMID:16584549 | 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:1353008 | 6480464 | bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA] | CTD | PMID:21273127 | 8-bromo-3',5'-cyclic AMP | multiple interactions | ISO | RGD:733207 | 6480464 | [NR5A1 protein co-treated with 8-Bromo Cyclic Adenosine Monophosphate] affects the expression of HSD17B2 mRNA | CTD | PMID:21610156 | 8-bromo-3',5'-cyclic AMP | increases expression | ISO | RGD:1353008 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA, 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 protein | CTD | PMID:18815356, PMID:21273127 | acetoacetyl-CoA | affects binding | ISO | RGD:1353008 | 6480464 | acetoacetyl CoA binds to HSD17B2 protein | CTD | PMID:25526675 | aflatoxin B1 | affects expression | ISO | RGD:1353008 | 6480464 | Aflatoxin B1 affects the expression of HSD17B2 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases methylation | ISO | RGD:1353008 | 6480464 | Aflatoxin B1 results in decreased methylation of HSD17B2 gene | CTD | PMID:27153756 | aldrin | increases expression | ISO | RGD:733207 | 6480464 | Aldrin results in increased expression of HSD17B2 mRNA | CTD | PMID:18579281 | all-trans-retinoic acid | increases expression | ISO | RGD:1353008 | 6480464 | Tretinoin results in increased expression of HSD17B2 mRNA | CTD | PMID:16249480 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of HSD17B2 mRNA | CTD | PMID:16483693 | androst-4-ene-3,17-dione | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Androstenedione | CTD | PMID:16054388 | androst-5-ene-3beta,17beta-diol | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Androstenediol | CTD | PMID:16054388 | androst-5-ene-3beta,17beta-diol | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Androstenediol | CTD | PMID:16054388 | antimony(0) | decreases expression | ISO | RGD:1353008 | 6480464 | Antimony results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 | arsane | affects methylation | ISO | RGD:1353008 | 6480464 | Arsenic affects the methylation of HSD17B2 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RGD:1353008 | 6480464 | Arsenic affects the methylation of HSD17B2 gene | CTD | PMID:25304211 | arsenous acid | decreases expression | ISO | RGD:1353008 | 6480464 | Arsenic Trioxide results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of HSD17B2 mRNA | CTD | PMID:22285353 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of HSD17B2 gene | CTD | PMID:28931070 | benzo[a]pyrene | increases expression | ISO | RGD:1353008 | 6480464 | Benzo(a)pyrene results in increased expression of HSD17B2 mRNA | CTD | PMID:20106945 | benzo[a]pyrene diol epoxide I | affects expression | ISO | RGD:1353008 | 6480464 | 7 more ... | CTD | PMID:20382639 | Benzo[k]fluoranthene | decreases expression | ISO | RGD:733207 | 6480464 | benzo(k)fluoranthene results in decreased expression of HSD17B2 mRNA | CTD | PMID:26377693 | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HSD17B2 mRNA | CTD | PMID:18164116 | bexarotene | decreases expression | EXP | | 6480464 | bexarotene results in decreased expression of HSD17B2 mRNA | CTD | PMID:16648578 | bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:733207 | 6480464 | Diethylhexyl Phthalate results in increased expression of HSD17B2 mRNA | CTD | PMID:27405655 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:1353008 | 6480464 | Diethylhexyl Phthalate results in decreased expression of HSD17B2 mRNA | CTD | PMID:31163220 | bisphenol A | multiple interactions | ISO | RGD:1353008 | 6480464 | bisphenol A inhibits the reaction [8-Bromo Cyclic Adenosine Monophosphate results in increased expression of HSD17B2 mRNA] | CTD | PMID:21273127 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of HSD17B2 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of HSD17B2 mRNA | CTD | PMID:22285353, PMID:25181051 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of HSD17B2 mRNA | CTD | PMID:25993096 | cadmium dichloride | decreases expression | ISO | RGD:1353008 | 6480464 | Cadmium Chloride results in decreased expression of HSD17B2 mRNA | CTD | PMID:26472689 | calcitriol | multiple interactions | ISO | RGD:1353008 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of HSD17B2 mRNA, Ketoconazole promotes the reaction [Calcitriol results in increased expression of HSD17B2 mRNA] | CTD | PMID:12040012, PMID:21592394 | calcitriol | increases expression | ISO | RGD:1353008 | 6480464 | Calcitriol results in increased expression of HSD17B2 mRNA | CTD | PMID:12040012 more ... | carbon nanotube | decreases expression | ISO | RGD:733207 | 6480464 | Nanotubes, Carbon results in decreased expression of HSD17B2 mRNA | CTD | PMID:25620056 | cefaloridine | decreases expression | EXP | | 6480464 | Cephaloridine results in decreased expression of HSD17B2 mRNA | CTD | PMID:18500788 | chromium(6+) | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of HSD17B2 mRNA] | CTD | PMID:18602937 | chromium(6+) | decreases expression | EXP | | 6480464 | chromium hexavalent ion results in decreased expression of HSD17B2 mRNA | CTD | PMID:18602937 | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of HSD17B2 mRNA | CTD | PMID:22023808 | copper atom | multiple interactions | ISO | RGD:1353008 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of HSD17B2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | RGD:1353008 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of HSD17B2 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | RGD:1353008 | 6480464 | Copper Sulfate results in decreased expression of HSD17B2 mRNA | CTD | PMID:19549813 | crocidolite asbestos | increases expression | ISO | RGD:1353008 | 6480464 | Asbestos, Crocidolite results in increased expression of HSD17B2 mRNA | CTD | PMID:25351596 | cyclosporin A | decreases expression | ISO | RGD:1353008 | 6480464 | Cyclosporine results in decreased expression of HSD17B2 mRNA | CTD | PMID:20106945 more ... | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of HSD17B2 mRNA | CTD | PMID:23640034 | dehydroepiandrosterone | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Dehydroepiandrosterone | CTD | PMID:16054388 | dehydroepiandrosterone | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Dehydroepiandrosterone | CTD | PMID:16054388 | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of HSD17B2 mRNA | CTD | PMID:20607812 | diarsenic trioxide | decreases expression | ISO | RGD:1353008 | 6480464 | Arsenic Trioxide results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 | dienogest | decreases expression | ISO | RGD:1353008 | 6480464 | dienogest results in decreased expression of HSD17B2 mRNA | CTD | PMID:23183084 | diethyl maleate | decreases expression | EXP | | 6480464 | diethyl maleate results in decreased expression of HSD17B2 mRNA | CTD | PMID:21161181 | dioxygen | increases expression | ISO | RGD:1353008 | 6480464 | Oxygen deficiency results in increased expression of HSD17B2 mRNA | CTD | PMID:26516004 | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | decreases expression | ISO | RGD:1353008 | 6480464 | Antimony Potassium Tartrate results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 | diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of HSD17B2 mRNA | CTD | PMID:21551480 | diuron | increases expression | ISO | RGD:1353008 | 6480464 | Diuron metabolite results in increased expression of HSD17B2 mRNA | CTD | PMID:24172598 | dydrogesterone | increases expression | ISO | RGD:1353008 | 6480464 | Dydrogesterone results in increased expression of HSD17B2 protein | CTD | PMID:23183084 | dydrogesterone | decreases expression | ISO | RGD:1353008 | 6480464 | Dydrogesterone results in decreased expression of HSD17B2 mRNA | CTD | PMID:23183084 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of HSD17B2 mRNA | CTD | PMID:29391264 | epoxiconazole | increases expression | EXP | | 6480464 | epoxiconazole results in increased expression of HSD17B2 mRNA | CTD | PMID:25182419 | estrone | increases chemical synthesis | ISO | RGD:1353008 | 6480464 | HSD17B2 protein results in increased chemical synthesis of Estrone | CTD | PMID:16054388 | estrone | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Estrone | CTD | PMID:16054388 | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of HSD17B2 mRNA | CTD | PMID:23962444 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of HSD17B2 mRNA | CTD | PMID:15120968 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of HSD17B2 gene | CTD | PMID:22079235 | glafenine | decreases expression | EXP | | 6480464 | Glafenine results in decreased expression of HSD17B2 mRNA | CTD | PMID:24136188 | graphite | affects expression | EXP | | 6480464 | Graphite affects the expression of HSD17B2 mRNA | CTD | PMID:29933104 | hexachlorobenzene | decreases expression | EXP | | 6480464 | Hexachlorobenzene results in decreased expression of HSD17B2 mRNA | CTD | PMID:15159207 | hydrogen peroxide | affects expression | ISO | RGD:1353008 | 6480464 | Hydrogen Peroxide affects the expression of HSD17B2 mRNA | CTD | PMID:20044591 | hydroquinone | increases expression | ISO | RGD:1353008 | 6480464 | hydroquinone results in increased expression of HSD17B2 mRNA | CTD | PMID:31256213 | ketoconazole | multiple interactions | ISO | RGD:1353008 | 6480464 | Ketoconazole promotes the reaction [Calcitriol results in increased expression of HSD17B2 mRNA] | CTD | PMID:12040012 | L-ascorbic acid | multiple interactions | EXP | | 6480464 | Ascorbic Acid inhibits the reaction [chromium hexavalent ion results in decreased expression of HSD17B2 mRNA] | CTD | PMID:18602937 | leflunomide | increases expression | ISO | RGD:1353008 | 6480464 | leflunomide results in increased expression of HSD17B2 mRNA | CTD | PMID:28988120 | medroxyprogesterone acetate | decreases expression | ISO | RGD:1353008 | 6480464 | Medroxyprogesterone Acetate results in decreased expression of HSD17B2 mRNA | CTD | PMID:23183084 | mercury dichloride | decreases expression | EXP | | 6480464 | Mercuric Chloride results in decreased expression of HSD17B2 mRNA | CTD | PMID:16507785 | methoxychlor | decreases expression | EXP | | 6480464 | Methoxychlor results in decreased expression of HSD17B2 mRNA | CTD | PMID:22285353 | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of HSD17B2 mRNA | CTD | PMID:19638242 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of HSD17B2 mRNA | CTD | PMID:18164116 | N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of HSD17B2 mRNA | CTD | PMID:25380136 | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of HSD17B2 mRNA | CTD | PMID:17072980 | N-nitrosodimethylamine | decreases expression | ISO | RGD:1353008 | 6480464 | Dimethylnitrosamine results in decreased expression of HSD17B2 mRNA | CTD | PMID:17547211 | NAD zwitterion | multiple interactions | ISO | RGD:1353008 | 6480464 | NAD binds to and results in increased activity of HSD17B2 protein | CTD | PMID:25526675 | NAD(+) | multiple interactions | ISO | RGD:1353008 | 6480464 | NAD binds to and results in increased activity of HSD17B2 protein | CTD | PMID:25526675 | nevirapine | decreases expression | EXP | | 6480464 | Nevirapine metabolite results in decreased expression of HSD17B2 mRNA | CTD | PMID:23947594 | paracetamol | affects expression | ISO | RGD:733207 | 6480464 | Acetaminophen affects the expression of HSD17B2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | ISO | RGD:1353008 | 6480464 | Acetaminophen results in increased expression of HSD17B2 mRNA | CTD | PMID:22230336 | paracetamol | decreases expression | ISO | RGD:1353008 | 6480464 | Acetaminophen results in decreased expression of HSD17B2 mRNA | CTD | PMID:21420995, PMID:29067470 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of HSD17B2 mRNA | CTD | PMID:15120968 | PD 0325901 | multiple interactions | ISO | RGD:1353008 | 6480464 | [(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of HSD17B2 mRNA | CTD | PMID:25119042 | PD 0325901 | decreases expression | ISO | RGD:1353008 | 6480464 | PD 0325901 results in decreased expression of HSD17B2 mRNA | CTD | PMID:25119042 | perfluorooctanoic acid | decreases expression | ISO | RGD:733207 | 6480464 | perfluorooctanoic acid results in decreased expression of HSD17B2 mRNA | CTD | PMID:20118188 | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of HSD17B2 mRNA | CTD | PMID:19162173 | perfluorooctanoic acid | multiple interactions | ISO | RGD:733207 | 6480464 | PPARA promotes the reaction [perfluorooctanoic acid results in increased expression of HSD17B2 mRNA] | CTD | PMID:20118188 | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of HSD17B2 mRNA | CTD | PMID:19162173 | phenobarbital | affects expression | ISO | RGD:733207 | 6480464 | Phenobarbital affects the expression of HSD17B2 mRNA | CTD | PMID:23091169 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of HSD17B2 mRNA | CTD | PMID:19162173 | pirinixic acid | decreases expression | ISO | RGD:733207 | 6480464 | pirinixic acid results in decreased expression of HSD17B2 mRNA | CTD | PMID:18445702, PMID:23811191 | pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of HSD17B2 mRNA | CTD | PMID:19162173 | prochloraz | increases expression | EXP | | 6480464 | prochloraz results in increased expression of HSD17B2 mRNA | CTD | PMID:25182419 | progesterone | multiple interactions | ISO | RGD:1353008 | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of HSD17B2 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of HSD17B2 mRNA | CTD | PMID:17404688, PMID:20660070 | progesterone | decreases expression | ISO | RGD:1353008 | 6480464 | Progesterone results in decreased expression of HSD17B2 mRNA, Progesterone results in decreased expression of HSD17B2 protein | CTD | PMID:23183084 | promegestone | multiple interactions | ISO | RGD:1353008 | 6480464 | mithramycin A inhibits the reaction [Promegestone promotes the reaction [SP1 protein binds to HSD17B2 promoter]] more ... | CTD | PMID:16807381 | quercetin | decreases expression | ISO | RGD:1353008 | 6480464 | Quercetin results in decreased expression of HSD17B2 mRNA | CTD | PMID:21632981 | rac-lactic acid | decreases expression | ISO | RGD:1353008 | 6480464 | Lactic Acid results in decreased expression of HSD17B2 mRNA | CTD | PMID:30851411 | resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of HSD17B2 mRNA | CTD | PMID:19228061 | resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Streptozocin] results in decreased expression of HSD17B2 mRNA | CTD | PMID:25905778 | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of HSD17B2 mRNA | CTD | PMID:28374803 | sevoflurane | affects expression | EXP | | 6480464 | sevoflurane affects the expression of HSD17B2 mRNA | CTD | PMID:15967596 | sodium arsenite | affects methylation | ISO | RGD:1353008 | 6480464 | sodium arsenite affects the methylation of HSD17B2 gene | CTD | PMID:28589171 | sodium arsenite | decreases expression | ISO | RGD:1353008 | 6480464 | sodium arsenite results in decreased expression of HSD17B2 mRNA | CTD | PMID:29301061 | streptozocin | multiple interactions | EXP | | 6480464 | [resveratrol co-treated with Streptozocin] results in decreased expression of HSD17B2 mRNA | CTD | PMID:25905778 | tamoxifen | affects expression | ISO | RGD:733207 | 6480464 | Tamoxifen affects the expression of HSD17B2 mRNA | CTD | PMID:20937368 | tert-butyl hydroperoxide | increases expression | ISO | RGD:733207 | 6480464 | tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA | CTD | PMID:15003993 | testosterone | affects metabolic processing | ISO | RGD:1353008 | 6480464 | HSD17B2 protein affects the metabolism of Testosterone | CTD | PMID:16054388 | testosterone | increases expression | ISO | RGD:1353008 | 6480464 | Testosterone results in increased expression of HSD17B2 mRNA | CTD | PMID:21592394 | testosterone | multiple interactions | ISO | RGD:1353008 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of HSD17B2 mRNA | CTD | PMID:21592394 | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of HSD17B2 mRNA | CTD | PMID:16239168 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of HSD17B2 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of HSD17B2 mRNA | CTD | PMID:31150632 | tetrachloromethane | decreases expression | ISO | RGD:733207 | 6480464 | Carbon Tetrachloride results in decreased expression of HSD17B2 mRNA | CTD | PMID:27339419 | tetracycline | increases expression | ISO | RGD:733207 | 6480464 | Tetracycline results in increased expression of HSD17B2 mRNA | CTD | PMID:16917069 | triadimefon | decreases expression | ISO | RGD:733207 | 6480464 | triadimefon results in decreased expression of HSD17B2 mRNA | CTD | PMID:16730040 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of HSD17B2 mRNA | CTD | PMID:21515302 | zearalenone | increases expression | EXP | | 6480464 | Zearalenone results in increased expression of HSD17B2 mRNA | CTD | PMID:20607812 | zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of HSD17B2 mRNA | CTD | PMID:15671213 | zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of HSD17B2 mRNA | CTD | PMID:15671213 | zoledronic acid | increases expression | ISO | RGD:1353008 | 6480464 | zoledronic acid results in increased expression of HSD17B2 mRNA | CTD | PMID:24714768 | |

Biological Process
Cellular Component
Molecular Function
